|
|
||||||||
Department of Molecular and Medical Genetics, University of Toronto, Medical Sciences Building, 1 Kings College Circle, Toronto, Ontario, Canada M5S 1A8
(Requests for offprints should be addressed to J E Aubin; Email: jane.aubin{at}utoronto.ca)
(S Zhang is now at Division of Genetic Services, Department of Pathology and Molecular Medicine, Kingston General Hospital, Queens University, Kingston, ON, Canada K7 L 2 V7)
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The steroid hormone 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) has diverse effects on many cell lineages, including osteoblasts where it affects proliferation, apoptosis, specific bone protein expression as well as mineralization (reviewed in van Driel et al. 2004). In the RC cell model, 1,25(OH)2D3 inhibits bone nodule formation while concomitantly increasing the number of adipocyte foci (Bellows et al. 1994). However, it is not yet clear whether 1,25(OH)2D3 acts separately to inhibit committed osteoprogenitors and stimulate adipocyte precursors and/or whether 1,25(OH)2D3 induces an adipogenic fate in bipotential osteoadipoprogenitors or both. To address this issue, and dissect the presence and responsiveness of other multi-lineage mesenchymal precursors in RC cell populations, we analyzed gene expression profiles in untreated and 1,25(OH)2D3-treated single cell-derived RC colonies.
| Materials and methods |
|---|
|
|
|---|
All procedures were approved by the University of Toronto Animal Care Committee. Fetal (E2021) rat calvaria cells were harvested by serial enzymatic digestion as previously described (Bellows et al. 1986). Cells recovered from the last four of five enzymatic digestions were cultured overnight in T-75 flasks containing
-MEM, 10% fetal bovine serum (FBS) and antibiotics (0.1 mg/ml penicillin G, 50 µg/ml gentamycin sulfate, 0.25 µg/ml fungizone), harvested with 0.2% trypsin, re-plated in 10-cm tissue culture dishes at a density of 104/cm2 and incubated at 37° C, 5% CO2 for another 5 days. Medium was changed every 2 or 3 days. Cells were recovered by trypsinization, washed and re-suspended in Hanks Balanced Salt Solution containing 2% FBS and 1 mM HEPES.
Single cell-derived RC cell colonies were obtained by sorting single cells into individual wells of 96-well cell culture dishes by fluorescence activated cell sorting (FACS) using a MoFlow equipped with an automatic cell deposition unit (ACDU) (Cytomation, Fort Collins, CO, USA). The cells were cultured in
-MEM containing 10% FBS, antibiotics, ascorbic acid (50 µg/ml), ß-glycerophosphate (10 mM) and dexamethasone (108 M) at 37°C in a 5% CO2 humidified incubator for 4 weeks. Parallel cultures were treated in the same medium but with 108 M 1,25(OH)2D3 (Sigma Co.).
At the end of 4 weeks, each well was examined by phase contrast microscopy; wells with identifiable colonies were marked and cells were lyzed with 350 µl RLT budffer (RNeasy, Qiagen) and stored at 80° C for RNA analysis.
RNA isolation, reverse transcription and real time PCR
Harvested colonies were randomly selected, total RNA was extracted with an RNeasy Mini kit (Qiagen) according to the manufacturers instructions, and samples were further digested with DNase (Qiagen). First strand cDNA was synthesized with SuperScript II reverse transcriptase and oligo-dT primer according to the manufacturers instructions (Invitrogen Inc.), and further purified and precipitated according to the protocol of Liss (2002). Real time PCR was performed on an ABI Prism 7000 Sequence Detection System (Applied Biosystems Inc., Foster City, CA, USA) with SYBR Green PCR Master Mix (Applied Biosystems) as buffer and source of fluorescence. A total of 50 cycles of amplification was used for all transcripts. Primer sequences, concentrations and annealing temperatures are listed in Table 1
for individual genes. An example of real-time PCR amplification of lineage-specific transcripts is shown in Fig. 1
.
|
|
Immunocytochemistry
For immunocytochemical analysis of nestin and ß3 tubulin, single cells were inoculated and cultured as described above. At times as indicated, cells were fixed in fresh 4% paraformaldehyde, washed with PBS and incubated with antibodies against nestin (1:400, BD Biosciences, San Jose, CA, USA) or ß3 tubulin (1:500, Covance Inc., Princeton, NJ, USA), washed, then incubated with FITC-conjugated donkey anti-mouse IgG (1:200, Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA). Secondary antibody alone served as a negative control. After immunostaining, cell nuclei were counterstained with Hoechst 33258.
Statistical analysis
Comparison of the distribution of different types of progenitors in control and 1,25(OH)2D3 treatment groups was performed using a hypergeometric algorithm developed by Adams and Skopek, a generalization of Fishers exact test for tables with more than two rows and two columns (Adams & Skopek 1987, Cariello et al. 1994). A two-tail Chi-square test for multiple rows was employed to compare individual lineages in different categories (single lineage, bi-lineage etc.) using a GraphPad Instat software package (GraphPad Software Inc., San Diego, CA, USA).
| Results |
|---|
|
|
|---|
In each experiment, fifteen 96-well culture dishes were used (total ~3000 wells inoculated at 1 cell/well). In the control group, approximately 9% of wells had colonies (4.7 and 13.3% in two independent experiments), while in the 1,25(OH)2D3 treatment group, approximately 8.7% (8.1 and 9.3%) of wells had colonies. There was no statistical difference in the colony forming effciency between the control and the 1,25(OH)2D3 treatment groups.
The frequency of mesenchymal lineage progenitors in RC cell populations
Amongst 134 and 75 independent colonies collected from the two groups, 60 colonies from each group were randomly selected for analysis by real-time PCR. From these, a total of 50 control and 49 1,25(OH)2D3-treated colonies were selected for lineage-specific expression profiling based on their similar level of expression of the housekeeping gene (ribosomal protein L32; detected by threshold cycle (Ct) value). The frequency of the different types of colonies from the control and 1,25(OH)2D3 treatment groups is summarized below and shown in Table 2
(the Ct values for expression of particular transcripts in individual colonies are available upon request).
|
Expression of neural markers in single cell-derived RC cell colonies
Given the high proportion of multi-lineage colonies observed and the fact that the parietal bone used for RC cell isolation derives from neuroectoderm, we next asked whether neural markers (nestin and ß3 tubulin) were expressed in any of the colonies isolated. Strikingly, 45 (90%) colonies in the control group expressed nestin and/or ß3 tubulin (34 expressed both markers; Table 2
), and this frequency was not changed by 1,25(OH)2D3 treatment (42 expressed nestin and/or ß3 tubulin; 24 expressed both). Neural marker expression was seen across all mesenchymal colony types, and 1,25(OH)2D3 did not change the distribution (P > 0.05; Table 2
). Amongst colonies designated CFC-F on the basis of the absence of all mesenchymal lineages tested, 1 of 2 in the control and 3 of 8 in the 1,25(OH)2D3 treatment groups had expressed neural markers.
To test whether nestin and ß3 tubulin protein expression occurred, 22 colonies from parallel wells as used for mRNA analysis were immunostained; neither nestin nor ß3 tubulin was detected in any of the colonies (data not shown).
| Discussion |
|---|
|
|
|---|
Consistent with our previous estimates by limiting dilution cloning (Aubin et al. 1982, Grigoriadis et al. 1988, 1990) and osteoprogenitor frequency analysis (Bellows & Aubin 1989), ~ 8% of primary RC cells are capable of colony formation, suggesting that the majority of the population comprises relatively mature cells lacking colony forming capacity. Concomitantly, a large proportion (86%) of colonies are multipotential (at least bi- but also tri- and tetra-potential) on the basis of simultaneous expression of markers for multiple mesenchymal lineages. These data support the presence of a mesenchymal cell hierarchy in primary RC cell populations, with a preponderance of multipotential precursors amongst the colony-forming cells. A mesenchymal cell lineage hierarchy was suggested earlier in stromal tissues and clonally derived RC cell populations (Grigoriadis et al. 1988, 1990, Owen & Friedenstein 1988, Friedenstein 1995). Notably, however, we have found that the presence of each type of precursor was not evenly distributed in the RC cell analysis, e.g. about one third of precursors were of the CFC-O/A/C type. This might indicate a default lineage selection under the osteogenic and 1,25(OH)2D3 treatment conditions used here, in keeping with the view that extrinsic factors can alter stem cell fate determination (Shah et al. 1994, 1996, Morrison et al. 1995).
In the current studies, RC colonies were defined based on mRNA expression patterns, not on functional criteria such as capacity of a single colony to give rise to more than one differentiated mesenchymal cell type after re-plating under appropriate culture conditions. We showed previously by clonal analyses that such functionally multipotential RC cells exist, but the strategy used to expand cells for testing also caused spontaneous immortalization of the isolated colonies (Grigoriadis et al. 1988, 1990). It remains a challenge to prove directly and without expansion/immortalization that single colonies expressing transcripts of multiple mesenchymal lineages are indeed primed for differentiation along these multiple mesenchymal lineages, since for most of the mesenchymal lineages the only reproducible differentiation culture conditions require cells to achieve high density in colonies (e.g. osteogenesis; Malaval et al. 1999) or require high initial plating cell density (e.g. chondrogenesis; Grigoriadis et al. 1988, Denker et al. 1999). However, evidence from hemopoietic cells suggests a dynamic development process of promiscuous expression or lineage primed progenitors that may contribute to flexibility and accessibility of multiple fate choices in particular progenitor populations (Miyamoto et al. 2002). Multilineage gene expression has also been detected in human bone marrow mesenchymal stem cells (Seshi et al. 2003). It is also worth noting, given the lineage markers we used, that expression of mature lineage markers in progenitors does not appear to affect their developmental potential; for example, transplanted hemopoietic stem cells expressing the myeloid lysozyme gene repopulate all hempoietic lineages (Ye et al. 2003). Such data have led to a lineage priming model for stem cell differentiation, i.e. genes indicating multi-lineage potential are promiscuously expressed preceding commitment to a single lineage (Hu et al. 1997, Enver & Greaves 1998, Seshi et al. 2000, 2003, Miyamoto et al. 2002, Woodbury et al. 2002). Our data obtained from single RC cell-derived progenitors are consistent with such a model. The hierarchical distribution amongst colony types (tetra-, tri-, bi- and mono-lineage) in RC cell populations suggests that when individual multipotential mesenchymal stem or progenitor cells differentiate to more committed progenitors, the genes responsible for other non-selected lineages are extinguished. Similar to hemopoietic stem cells (Ye et al. 2003), in a primed stage, individual RC progenitor cells may express genes encoding lineage exclusive functions (e.g. BSP, adipsin, collagen II, etc), but remain in an apparent state of indecision.
Interestingly, the proportion of tri- and tetra-lineage colonies was not changed after 1,25(OH)2D3 treatment, suggesting developmental stage-specific effects 1,25(OH)2D3of on RC mesenchymal progenitors. The developmental stage-dependent recruitment of 1,25(OH)2D3 on different precursors may contribute to the biphasic effects of 1,25(OH)2D3 described previously on adipocyte-osteoblast differentiation (Owen et al. 1991, Ishida et al. 1993, Kelly & Gimble 1998, Atmani et al. 2002). However, the frequency of other progenitor cell types is affected. For example, the frequency of CFC-C was increased after 1,25(OH)2D3 treatment, suggesting a stimulatory effect of 1,25(OH)2D3 on chondrogenesis.1,25(OH)2D3 also decreased the frequency of osteoblast/chondrocyte progenitors (from 20% to 6%; P = 0.03 by one-tail Chi-square test). Although the statistical robustness of the observation is relatively low, the increased CFC-C and decreased CFC-O/C frequency suggests that 1,25(OH)2D3 stimulates chondrogenesis by recruitment from the CFC-O/C progenitor pool. However, we cannot rule out an effect of 1,25(OH)2D3 on other pathways that may contribute to the CFC-C pool.
The frequency of osteoblast/adipocyte bipotential progenitors has been predicted to be ~5% in primary RC cell populations (Bellows & Heersche 2001). Such cells are detectable at somewhat higher frequency by histological assessment of single cell-derived colonies in very low density cultures after 1,25(OH)2D3 treatment, where about a quarter of total colonies (25.2 ± 10%) are stained for lipid (Oil red O) and for the presence of the osteoblast marker alkaline phosphatase, whereas only alkaline phosphatase-positive colonies are detectable in the control group (authors unpublished data). Consistent with previous studies in high density cultures (Ishida et al. 1993, Bellows et al. 1994, Bellows & Heersche 2001), 1,25(OH)2D3 treatment resulted in loss of CFC-O, indicating an inhibitory effect of 1,25(OH)2D3 on committed osteoprogenitors in RC cell cultures. Data such as these have contributed to the hypothesis that the fates of osteoblast versus adipocyte are reciprocally related in RC and stromal cell populations (reviewed in Nuttall & Gimble 2000, Aubin & Trifftt 2003, Gimble & Nuttall 2004). Notably, however, the loss of CFC-O was not accompanied by an increase in CFC-A frequency in our studies, but instead by a significant increase in frequency of CFC-O/A bipotential progenitors (0% to 8%), suggesting that the reciprocal effects of 1,25(OH)2D3 on osteogenesis and adipogenesis are mediated by the enhanced recruitment of CFC-O/A. Because 1,25(OH)2D3 did not affect the frequencies of tri- and tetrapotential colonies, a dedifferentiation process of CFC-O to CFC-O/A may underlie the decreased CFC-O and increased CFC-O/A frequency observed.
Some progenitors were identified as CFC-Fs in the current study based on absence of expression of any of the mesenchymal lineage markers tested. Such cells may represent a very primitive mesenchymal progenitor or they may belong to lineages for which markers were not tested. In either case, 1,25(OH)2D3 significantly increased the frequency of CFC-Fs (P = 0.04), suggesting that 1,25(OH)2D3 either re-directs some progenitors towards other mesenchymal lineages or dedifferentiates progenitors to a more primitive stem cell stage. Dedifferentiation was suggested to be responsible for the observation that highly differentiated adipocytes revert to a less differentiated, more proliferative fibroblastic precursor and then to an osteogenic phenotype under certain culture conditions (Park et al. 1999). Based on CFC-Fs and the other colony types observed, we propose that 1,25(OH)2D3 alters the fate choice of mesenchymal lineage precursors at several bifurcation points as summarized in Fig. 2
.
|
In conclusion, single RC cell-derived colonies define a mesenchymal cell lineage hierarchy in which 1,25(OH)2D3 alters fate choices in a developmental stage-specific manner.
| Acknowledgements |
|---|
| Funding |
|---|
This work was supported by grants from the Canadian Institutes of Health Research (MT12390) and the Stem Cell Network of Centres of Excellence to J E A. The authors declare that there is no conflict of interest that would prejudice the impartiality of this scientific work.
| References |
|---|
|
|
|---|
Atmani H, Audrain C, Mercier L, Chappard D & Basle MF 2002 Phenotypic effects of continuous or discontinuous treatment with dexamethasone and/or calcitriol on osteoblasts differentiated from rat bone marrow stromal cells. Journal of Cellular Biochemistry 85 640650.[Medline]
Aubin JE 1998 Bone stem cells. Journal of Cellular Biochemistry Supplement 3031 7382.
Aubin JE & Trifftt JT 2003 Mesenchymal stem cells and osteoblast differentiation. In Principles of Bone Biology, edn 2, pp 5981. Eds JP Bilezikian, LG Raisz & GA Rodan. San Diego: Academic Press Ltd.
Aubin JE, Heersche JN, Merrilees MJ & Sodek J 1982 Isolation of bone cell clones with differences in growth, hormone responses, and extracellular matrix production. Journal of Cell Biolog y 92 452461.
Bellows CG & Aubin JE 1989 Determination of numbers of osteoprogenitors present in isolated fetal rat calvaria cells in vitro. Developmental Biology 133 813.[CrossRef][Web of Science][Medline]
Bellows CG & Heersche JN 2001 The frequency of common progenitors for adipocytes and osteoblasts and of committed and restricted adipocyte and osteoblast progenitors in fetal rat calvaria cell populations. Journal of Bone and Mineral Research 16 19831993.[CrossRef][Medline]
Bellows CG, Aubin JE, Heersche JN & Antosz ME 1986 Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcified Tissue International 38 143154.[Web of Science][Medline]
Bellows CG, Heersche JN & Aubin JE 1989 Effects of dexamethasone on expression and maintenance of cartilage in serum-containing cultures of calvaria cells. Cell and Tissue Research 256 145151.[Medline]
Bellows CG, Wang YH, Heersche JN & Aubin JE 1994 1,25-Dihydroxyvitamin D3 stimulates adipocyte differentiation in cultures of fetal rat calvaria cells: comparison with the effects of dexamethasone. Endocrinology 134 22212229.[Abstract]
Beresford JN, Bennett JH, Devlin C, Leboy PS & Owen ME 1992 Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. Journal of Cell Science 102 341351.
Bhargava U, Bar-Lev M, Bellows CG & Aubin JE 1988 Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cells. Bone 9 155163.[Medline]
Caplan AI 1991 Mesenchymal stem cells. Journal of Orthopaedic Research 9 641650.
Cariello NF, Piegorsch WW, Adams WT & Skopek TR 1994 Computer program for the analysis of mutational spectra: application to p53 mutations. Carcinogenesis 15 22812285.
Denker AE, Haas AR, Nicoll SB & Tuan RS 1999 Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells. I. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures. Differentiation 64 6776.[CrossRef][Web of Science][Medline]
Dorheim MA, Sullivan M, Dandapani V, Wu X, Hudson J, Segarini PR, Rosen DM, Aulthouse AL & Gimble JM 1993 Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells. Journal of Cellular Physiology 154 317328.[CrossRef][Web of Science][Medline]
van Driel M, Pols HA & van Leeuwen JP 2004 Osteoblast differentiation and control by vitamin D and vitamin D metabolites. Current Pharmaceutical Design 10 25352555.[CrossRef][Medline]
Enver T & Greaves M 1998 Loops, lineage, and leukemia. Cell 94 912.[CrossRef][Web of Science][Medline]
Friedenstein AJ 1995 Marrow stromal fibroblasts. Calcified Tissue International 56 Suppl 1 S17.
Gimble JM & Nuttall ME 2004 Bone and fat: old questions, new insights. Endocrine 23 183188.[CrossRef][Web of Science][Medline]
Grigoriadis AE, Heersche JN & Aubin JE 1988 Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone. Journal of Cell Biology 106 21392151.
Grigoriadis AE, Aubin JE & Heersche JN 1989 Effects of dexamethasone and vitamin D3 on cartilage differentiation in a clonal chondrogenic cell population. Endocrinology 125 21032110.
Grigoriadis AE, Heersche JN & Aubin JE 1990 Continuously growing bipotential and monopotential myogenic, adipogenic, and chondrogenic subclones isolated from the multipotential RCJ 3.1 clonal cell line. Developmental Biology 142 313318.[CrossRef][Web of Science][Medline]
Grigoriadis AE, Heersche JN & Aubin JE 1996 Analysis of chondroprogenitor frequency and cartilage differentiation in a novel family of clonal chondrogenic rat cell lines. Differentiation 60 299307.[CrossRef][Web of Science][Medline]
Hu M, Krause D, Greaves M, Sharkis S, Dexter M, Heyworth C & Enver T 1997 Multilineage gene expression precedes commitment in the hemopoietic system. Genes and Development 11 774785.
Ishida H, Bellows CG, Aubin JE & Heersche JN 1993 Characterization of the 1,25-(OH)2D3-induced inhibition of bone nodule formation in long-term cultures of fetal rat calvaria cells. Endocrinology 132 6166.
Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA & Verfaillie CM 2002 Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 4149.[CrossRef][Medline]
Kawai K, Tamaki A & Hirohata K 1985 Steroid-induced accumulation of lipid in the osteocytes of the rabbit femoral head. A histochemical and electron microscopic study. Journal of Bone and Joint Surgery. American Volume 67 755763.
Kelly KA & Gimble JM 1998 1,25-Dihydroxyvitamin D3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures. Endocrinology 139 26222628.
Kim M & Morshead CM 2003 Distinct populations of forebrain neural stem and progenitor cells can be isolated using side-population analysis. Journal of Neuroscience 23 1070310709.
Lindmark E & Siegbahn A 2002 Tissue factor regulation and cytokine expression in monocyte-endothelial cell co-cultures: effects of a statin, an ACE-inhibitor and a low-molecular-weight heparin. Thrombosis Research 108 77 84.[CrossRef][Web of Science][Medline]
Liss B 2002 Improved quantitative real-time RT-PCR for expression profiling of individual cells. Nucleic Acids Research 30 e89.
Malaval L, Liu F, Roche P & Aubin JE 1999 Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro. Journal of Cellular Biochemistry 74 616627.[CrossRef][Web of Science][Medline]
Meunier P, Aaron J, Edouard C & Vignon G 1971 Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clinical Orthopaedics 80 147154.
Miyamoto T, Iwasaki H, Reizis B, Ye M, Graf T, Weissman IL & Akashi K 2002 Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Developmental Cell 3 137147.[CrossRef][Web of Science][Medline]
Morrison SJ, Hemmati HD, Wandycz AM & Weissman IL 1995 The purification and characterization of fetal liver hematopoietic stem cells. PNAS 92 1030210306.
Nuttall ME & Gimble JM 2000 Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 27 177184.[Medline]
Orkin SH 2003 Priming the hematopoietic pump. Immunity 19 633634.[CrossRef][Web of Science][Medline]
Owen M & Friedenstein AJ 1988 Stromal stem cells: marrow-derived osteogenic precursors. Ciba Foundation Symposium 136 4260.[Medline]
Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS & Lian JB 1991 Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128 14961504.
Park SR, Oreffo RO & Trifftt JT 1999 Interconversion potential of cloned human marrow adipocytes in vitro. Bone 24 549554.[Medline]
Rifas L, Uitto J, Memoli VA, Kuettner KE, Henry RW & Peck WA 1982 Selective emergence of differentiated chondrocytes during serum-free culture of cells derived from fetal rat calvaria. Journal of Cell Biology 92 493504.
Seshi B, Kumar S & Sellers D 2000 Human bone marrow stromal cell: coexpression of markers specific for multiple mesenchymal cell lineages. Blood Cells, Molecules and Diseases 26 234246.[CrossRef][Medline]
Seshi B, Kumar S & King D 2003 Multilineage gene expression in human bone marrow stromal cells as evidenced by single-cell microarray analysis. Blood Cells, Molecules and Diseases 31 268285.[CrossRef][Web of Science][Medline]
Shah NM, Marchionni MA, Isaacs I, Stroobant P & Anderson DJ 1994 Glial growth factor restricts mammalian neural crest stem cells to a glial fate. Cell 77 349360.[CrossRef][Web of Science][Medline]
Shah NM, Groves AK & Anderson DJ 1996 Alternative neural crest cell fates are instructively promoted by TGFbeta superfamily members. Cell 85 331343.[CrossRef][Web of Science][Medline]
Suda T, Jimi E, Nakamura I & Takahashi N 1997 Role of 1 alpha,25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods in Enzymology 282 223235.[Web of Science][Medline]
Wang GJ, Sweet DE, Reger SI & Thompson RC 1977 Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. Journal of Bone and Joint Surgery. American Volume 59 729735.
Woodbury D, Schwarz EJ, Prockop DJ & Black IB 2000 Adult rat and human bone marrow stromal cells differentiate into neurons. Journal of Neuroscience Research 61 364370.[CrossRef][Web of Science][Medline]
Woodbury D, Reynolds K & Black IB 2002 Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. Journal of Neuroscience Research 69 908917.[CrossRef][Web of Science][Medline]
Ye M, Iwasaki H, Laiosa CV, Stadtfeld M, Xie H, Heck S, Clausen B, Akashi K & Graf T 2003 Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential. Immunity 19 689699.[CrossRef][Web of Science][Medline]
Zhang S, Uchida S, Inoue T, Chan M, Mockler E & Aubin JE 2005 Side population (SP) cells isolated from fetal rat calvaria are enriched for bone, cartilage, adipose tissue and neural progenitors. Bone (in press).
Received in final form 1 February 2006
Accepted 20 February 2006
This article has been cited by other articles:
![]() |
C. J. Narvaez, D. Matthews, E. Broun, M. Chan, and J. Welsh Lean Phenotype and Resistance to Diet-Induced Obesity in Vitamin D Receptor Knockout Mice Correlates with Induction of Uncoupling Protein-1 in White Adipose Tissue Endocrinology, February 1, 2009; 150(2): 651 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Aubin Close Encounters of the Bone-Blood Kind IBMS BoneKEy, January 1, 2008; 5(1): 25 - 29. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |